Twist Bioscience Raises FY2026 Sales Guidance from $435.000M-$440.000M to $442.000M-$447.000M vs $439.118M Est

Benzinga Newsdesk www.benzinga.com Positive 94.1%

Neg 0% Neu 0% Pos 94.1%

Twist Bioscience (NASDAQ:TWST) raises FY2026 sales outlook from $435.000 million-$440.000 million to $442.000 million-$447.000 million vs $439.118 million estimate.